CHANGES IN COAGULATION-FACTORS BY PASSAGE THROUGH A DEXTRAN SULFATE CELLULOSE COLUMN DURING LOW-DENSITY-LIPOPROTEIN APHERESIS

被引:38
作者
KOJIMA, S
HARADASHIBA, M
TOYOTA, Y
KIMURA, G
TSUSHIMA, M
KURAMOCHI, M
SAKATA, T
UCHIDA, K
YAMAMOTO, A
OMAE, T
机构
[1] NATL CARDIOVASC CTR,RES INST,DEPT ETIOL & PATHOPHYSIOL,SUITA,OSAKA 565,JAPAN
[2] NATL CARDIOVASC CTR HOSP & RES INST,DEPT CLIN LAB,SUITA,OSAKA 565,JAPAN
关键词
LOW DENSITY LIPOPROTEIN; PLASMAPHERESIS; COAGULATION FACTORS; HEPARIN; NAFAMOSTAT MESILATE; ANTICOAGULANTS; BRADYKININ;
D O I
10.1177/039139889201500309
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
To determine the extent of adsorption of coagulation factors by a dextran sulfate cellulose column used for selective removal of low-density lipoprotein (LDL), various coagulation factors were measured before and after application to the column during LDL apheresis. The column almost completely adsorbed many coagulation factors. Although the bradykinin concentration was markedly increased by passing the plasma through the column, this increment was suppressed by nafamostat mesilate which inhibits the initial contact phase of the intrinsic coagulation pathway. The von Willebrand factor, which forms a complex with factor VIII in plasma, is reduced in apheresis with nafamostat mesilate to the same extent as in apheresis without nafamostat mesilate. Thus, coagulation factors seem to be adsorbed by different mechanisms which include activation of the initial contact phase by the negative charges of dextran sulfate and concomitant adsorption with the phospholipid portion of lipoproteins containing apolipoprotein B or with von Willebrand factor.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 16 条
[1]   PHARMACOLOGICAL STUDIES OF FUT-175, NAFAMSTAT MESILATE .1. INHIBITION OF PROTEASE ACTIVITY IN INVITRO AND INVIVO EXPERIMENTS [J].
AOYAMA, T ;
INO, Y ;
OZEKI, M ;
ODA, M ;
SATO, T ;
KOSHIYAMA, Y ;
SUZUKI, S ;
FUJITA, M .
JAPANESE JOURNAL OF PHARMACOLOGY, 1984, 35 (03) :203-227
[2]  
DATI F, 1987, THROMB HAEMOSTASIS, V58, P856
[3]   MECHANISMS FOR INVOLVEMENT OF HIGH MOLECULAR-WEIGHT KININOGEN IN SURFACE-DEPENDENT REACTIONS OF HAGEMAN-FACTOR [J].
GRIFFIN, JH ;
COCHRANE, CG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1976, 73 (08) :2554-2558
[4]   RAPID IMMUNOTURBIDIMETRIC ASSAY OF ALBUMIN AND IMMUNOGLOBULIN-G IN SERUM AND CEREBROSPINAL-FLUID WITH AN AUTOMATIC DISCRETE ANALYZER [J].
KAMP, HH ;
LUDERER, TKJ ;
MULLER, HJ ;
SOPJESKRUK, A .
CLINICA CHIMICA ACTA, 1981, 114 (2-3) :195-205
[5]  
KOJIMA S, 1990, ASAIO T, V36, P380
[6]   HEMOSTATIC FUNCTION AND ISCHEMIC-HEART-DISEASE - PRINCIPAL RESULTS OF THE NORTHWICK-PARK-HEART-STUDY [J].
MEADE, TW ;
BROZOVIC, M ;
CHAKRABARTI, RR ;
HAINES, AP ;
IMESON, JD ;
MELLOWS, S ;
MILLER, GJ ;
NORTH, WRS ;
STIRLING, Y ;
THOMPSON, SG .
LANCET, 1986, 2 (8506) :533-537
[7]   ACTIVATION AND FUNCTION OF HUMAN HAGEMAN-FACTOR - ROLE OF HIGH MOLECULAR-WEIGHT KININOGEN AND PREKALLIKREIN [J].
MEIER, HL ;
PIERCE, JV ;
COLMAN, RW ;
KAPLAN, AP .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (01) :18-31
[8]   PLASMA BRADYKININ CONCENTRATION IN PATIENTS WITH ESSENTIAL-HYPERTENSION, EFFORT ANGINA AND OTHER CARDIAC DISEASES [J].
MINAMI, M ;
TOGASHI, H ;
SANO, M ;
ENDOH, T ;
SAITO, H ;
HASHIMOTO, F ;
FUJITA, K ;
YASUDA, H ;
KURIYAMOTO, Y ;
NISHINO, T .
FOLIA PHARMACOLOGICA JAPONICA, 1983, 82 (02) :159-169
[9]  
NAGANO Y, Patent No. 710211267
[10]  
Nemerson Y, 1990, HEMATOLOGY, P1267